AVTR
Avantor, Inc.
AVTR offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
LLY
Eli Lilly and Company
LLY has the edge over AVTR overall, supported by stronger fundamentals and stronger modeled upside.
AVTR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
AVTR's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
AVTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $15.62 | — |
| Cheap | 21x | $10.56 | -32% |
| Current | 31x | $15.62 | — |
| Fair | 41x | $20.70 | +33% |
| Expensive | 96x | $47.90 | +207% |
Historical ranges are pointers, not guarantees.
AVTR has the edge over LLY in the historical PE scenario, which offers more potential upside but is not a forecast.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
AVTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for AVTR, with profitability improving.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
AVTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.88 | +75% |
| Q3 2026 | $0.50 | +$0.63 |
| Q2 2026 | -$0.84 | -185% |
| Q1 2026 | -$0.81 | -178% |
| Q4 2025 | -$0.78 | -175% |
| Q3 2025 | -$0.13 | -129% |
| Q2 2025 | $0.99 | +87% |
| Q1 2025 | $1.04 | +174% |
| Q4 2024 | $1.04 | +121% |
AVTR has returned to profit: it earned $0.50 per share over the past year, after losing money the year before.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over AVTR on earnings, with more consistent year-over-year improvement.
AVTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +4.6% |
| Q2 2026 | $1.7B | +0.5% |
| Q1 2026 | $1.6B | 0% |
| Q4 2025 | $1.7B | -1.4% |
| Q3 2025 | $1.6B | -5.3% |
| Q2 2025 | $1.7B | -1.1% |
| Q1 2025 | $1.6B | -5.9% |
| Q4 2024 | $1.7B | -2.1% |
AVTR's revenue has held roughly level: $1.7B last quarter, up 4.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +48 points |
| Q2 2026 | 7.2% | -0.5 points |
| Q1 2026 | 6.3% | -3 points |
| Q4 2025 | 7.6% | -30 points |
| Q3 2025 | -40% | -47 points |
| Q2 2025 | 7.7% | -2.7 points |
| Q1 2025 | 9.3% | +0.6 points |
| Q4 2024 | 38% | +27 points |
AVTR's operating margin was 8.2% last quarter, up 48 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over AVTR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over AVTR on profitability, with a higher operating margin.
AVTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $156.2M | -9% |
| Q2 2026 | $140.6M | +13% |
| Q1 2026 | $25.2M | -69% |
| Q4 2025 | $117.2M | -20% |
| Q3 2025 | $171.7M | -16% |
| Q2 2025 | $124.8M | -47% |
| Q1 2025 | $81.3M | -24% |
| Q4 2024 | $145.8M | -27% |
AVTR's free cash flow has been positive every quarter for seven years: $439M over the past year, down 16% from the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over AVTR on cash flow, with more consistent year-over-year improvement.
AVTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +3.7M shares |
| 1 year | -0.1% | -800K shares |
| 3 years | +0.4% | +2.4M shares |
| 5 years | +14% | +82.8M shares |
| Available history | +17% | +99.6M shares |
AVTR has 681M diluted shares, about the same as a year ago.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over AVTR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
AVTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.6x | Elevated |
| Q2 2026 | 28.9x | High |
| Q1 2026 | 29.1x | High |
| Q4 2025 | 21.8x | High |
| Q3 2025 | 5.4x | High |
| Q2 2025 | 2.6x | Moderate |
| Q1 2025 | 2.5x | Moderate |
| Q4 2024 | 2.6x | Moderate |
AVTR's net debt is about 3.5 years of its operating earnings (EBITDA), down from 5.4 years a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY has the edge over AVTR on leverage, with a lower net debt burden relative to earnings.
AVTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.2 | Neutral |
| Stochastic | 62.4 | Neutral |
AVTR's weekly RSI is 64 (neutral) and its Stochastic is 62 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
AVTR PE vs Healthcare Sector
| Metric | AVTR | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 26x | 21% above |
| PE % | 33 | 29 | 4 pts above |
AVTR has the edge over LLY on valuation relative to its sector.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
AVTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.9 | 1.7% below |
| 20 week MA | $14.3 | 9.3% above |
| 50 week MA | $11.4 | 37% above |
| 100 week MA | $13.2 | 18% above |
| 200 week MA | $17.8 | 12% below |
AVTR's trend is mixed: it's above three of its five weekly moving averages, and 12% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over AVTR on trend strength, trading above more of its moving averages.
AVTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.2 | $27.1 | +49% |
| 2021 | $27.1 | $41.3 | +52% |
| 2022 | $41.3 | $20.5 | -50% |
| 2023 | $20.5 | $22.8 | +11% |
| 2024 | $22.8 | $21.4 | -6.2% |
| 2025 | $21.4 | $11.4 | -47% |
| 2026 YTD | $11.4 | $15.6 | +37% |
AVTR has the edge over LLY on returns for 2026, with the stronger performance.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.